Panacea Biotec Ltd

NSE: PANACEABIO · BSE: 531349 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹357.40
Market cap: ₹2,189 Cr
Revenue (annual): ₹639.8 Cr
Net profit (annual): ₹-5.37 Cr
P/E (TTM): -307.5×Sector 47.4×
Promoter holding: 72.48%+0.00% QoQ
FII holding: 2.31%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 6 Promoter Buying (Off-Market) 3 Other Announcement 3 New Order Win 3 Financial Results 3 Board Meeting Date 2 Management Change 1 Capital Structure Change 1 Annual General Meeting 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

13 Aug 2026 18:46 IST NSE

Financial Results

Panacea Biotec Q1 FY27 Results: Net Profit ₹2.2 Cr, Down 45.0% YoY

Panacea Biotec Ltd reported revenue from operations of ₹199.6 Cr (+19.7% YoY) and net profit of ₹2.2 Cr (-45.0% YoY) for Q1 FY27.

Key figure: Net profit ₹2.2 Cr · -45.0% YoY

Open full results → Read the filing ↗

30 May 2026 22:40 IST BSE

Financial Results

Panacea Biotec Q4 FY26 Results: Net Loss of ₹1 Cr, Loss Narrows

Panacea Biotec Ltd reported revenue from operations of ₹166.8 Cr (+25.9% YoY) and a net loss of ₹1 Cr for Q4 FY26.

Key figure: Net loss ₹1 Cr

Open full results → Read the filing ↗

30 May 2026 22:39 IST BSE

Financial Results

Panacea Biotec Financial Results

Panacea Biotec approved FY2026 audited financial results and skipped dividends due to losses. The board also appointed Rajinder Singh Manku as an Independent Director.

Read the filing ↗